efavirenz has been researched along with Asymptomatic Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagaratnam, J; Boffito, M; Bozzali, M; Cercignani, M; Mora-Peris, B; Nelson, M; Toniolo, S; Underwood, J; Vera, JH; Winston, A | 1 |
| Arends, JE; Hakkers, CS; Hermans, AM; Hoepelman, AIM; Teunissen, CE; van Maarseveen, EM; Verberk, IMW | 1 |
1 trial(s) available for efavirenz and Asymptomatic Conditions
| Article | Year |
|---|---|
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Asymptomatic Diseases; Attention; Benzoxazines; Biomarkers; Cognitive Dysfunction; Cyclopropanes; Executive Function; Female; HIV Infections; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Neurofilament Proteins; Rilpivirine; Speech | 2020 |
1 other study(ies) available for efavirenz and Asymptomatic Conditions
| Article | Year |
|---|---|
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asymptomatic Diseases; Benzoxazines; Cognitive Dysfunction; Connectome; Cyclopropanes; Drug Substitution; Emtricitabine; Executive Function; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxazines; Piperazines; Prospective Studies; Pyridones; Raltegravir Potassium; Rilpivirine; Tenofovir | 2020 |